CYCLOPHOSPHAMIDE CYSTITIS - IDENTIFICATION OF ACROLEIN AS THE CAUSATIVE AGENT
CYCLOPHOSPHAMIDE CYSTITIS - IDENTIFICATION OF ACROLEIN AS THE CAUSATIVE AGENT
复制标题
DOI:
10.1016/0006-2952(79)90222-3
复制
发表时间:
1979-01-01
影响因子:
5.8
通讯作者:
COX, PJ
中科院分区:
文献类型:
--
作者:
COX, PJ
Hemorrhagic cystitis of the bladder caused by the antitumour agents cyclophosphamide {2[bis(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide} and ifosfamide [3-(2-chloroethyl)-2-(2-chloroethylamino)tetrahydro-1,3,2-oxazaphosphorine 2-oxide] was studied in the rat. Optimum conditions in this model for protection from toxicity by N-acetyl-L-cysteine were found. Phosphoramide mustard, the ultimate alkylating metabolite of cyclophosphamide, and 5,5-dimethylcyclophosphamide, which is metabolized but forms no cytotoxic products, had minimal effects on the bladder. However, diethylcyclophosphamide [2-(diethylamino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide] caused severe cystitis in the male rat, and significant, but less extensive damage, in the female rat; N-acetyl-L-cysteine protection against this toxicity was demonstrated. As acrolein is the only reactive and cytotoxic metabolite of diethylcyclophosphamide, the role of acrolein as the causative agent in cyclophosphamide cystitis was proven.